538 related articles for article (PubMed ID: 21574991)
1. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
[TBL] [Abstract][Full Text] [Related]
2. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
Crowner BE; Racette BA
Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin injection of the subscapularis muscle.
Unlu E; Sen T; Umay E; Bal B; Elhan A; Cakci A
J Clin Neurosci; 2010 Oct; 17(10):1265-6. PubMed ID: 20591673
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
5. Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
Mirska A; Cybula K; Okurowska-Zawada B; Kułak W; Dmitruk E; Okulczyk K; Kalinowska AK
J Pediatr Orthop B; 2014 Nov; 23(6):517-22. PubMed ID: 25171568
[TBL] [Abstract][Full Text] [Related]
6. Motor endplate-targeted botulinum toxin injections of the gracilis muscle in children with cerebral palsy.
Van Campenhout A; Bar-On L; Desloovere K; Huenaerts C; Molenaers G
Dev Med Child Neurol; 2015 May; 57(5):476-83. PubMed ID: 25557985
[TBL] [Abstract][Full Text] [Related]
7. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy.
Yap R; Majnemer A; Benaroch T; Cantin MA
Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of botulinum toxin A in children with cerebral palsy.
Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y
Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845
[TBL] [Abstract][Full Text] [Related]
9. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
[TBL] [Abstract][Full Text] [Related]
10. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
11. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of spasticity in cerebral palsy with botulinum toxin].
Calderón-González R; Calderón-Sepúlveda RF
Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
Hawamdeh ZM; Ibrahim AI; Al-Qudah AA
Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388
[TBL] [Abstract][Full Text] [Related]
14. What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy?
Barrett RS
Dev Med Child Neurol; 2011 Jun; 53(6):485. PubMed ID: 21518344
[No Abstract] [Full Text] [Related]
15. Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.
Williams SA; Reid S; Elliott C; Shipman P; Valentine J
Dev Med Child Neurol; 2013 Sep; 55(9):813-20. PubMed ID: 23789782
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
Gibson N; Graham HK; Love S
Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
[TBL] [Abstract][Full Text] [Related]
19. Neurorehabilitation with versus without resistance training after botulinum toxin treatment in children with cerebral palsy: a randomized pilot study.
Bandholm T; Jensen BR; Nielsen LM; Rasmussen H; Bencke J; Curtis D; Pedersen SA; Sonne-Holm S
NeuroRehabilitation; 2012; 30(4):277-86. PubMed ID: 22672941
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of the motor cerebral palsy child with botulinum toxin A: mode of action, injection places in management].
Carrelet P; Bollini G; Mancini J; Chabrol B
Arch Pediatr; 2002 Sep; 9(9):928-33. PubMed ID: 12387176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
